{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:36Z","timestamp":1791910416475,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118298","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:55Z","timestamp":1785307135000},"page":"118298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["CSF1 inhibits ferroptosis in colorectal cancer cells by autocrine activation of the JAK\/STAT3 signaling pathway"],"prefix":"10.1016","volume":"253","author":[{"given":"Qiuyuan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1684-6150","authenticated-orcid":false,"given":"Xiaoping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118298_b0005","doi-asserted-by":"crossref","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021, 71(3):209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.bcp.2026.118298_b0010","unstructured":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol 2022, 7(7):627\u2013647."},{"key":"10.1016\/j.bcp.2026.118298_b0015","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, A. Goding Sauer, S.A. Fedewa, L.F. Butterly, J.C. Anderson, A. Cercek, R.A. Smith, A. Jemal, Colorectal cancer statistics, 2020. CA: a cancer journal for clinicians 2020, 70(3):145\u2013164.","DOI":"10.3322\/caac.21601"},{"issue":"4","key":"10.1016\/j.bcp.2026.118298_b0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer - a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118298_b0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: a Review","volume":"325","author":"Biller","year":"2021","journal-title":"J. Am. Med. Assoc."},{"issue":"16","key":"10.1016\/j.bcp.2026.118298_b0030","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","article-title":"Metastatic colorectal cancer: current state and future directions","volume":"33","author":"Fakih","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118298_b0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118298_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118298_b0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"51","key":"10.1016\/j.bcp.2026.118298_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2026.118298_b0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bcp.2026.118298_b0065","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.bcp.2026.118298_b0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118298_b0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.118298_b0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol."},{"issue":"21","key":"10.1016\/j.bcp.2026.118298_b0090","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1038\/onc.2014.226","article-title":"Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGF\u03b2 in claudin-low breast tumor cells","volume":"34","author":"Patsialou","year":"2015","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bcp.2026.118298_b0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/gcc.22481","article-title":"The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer","volume":"56","author":"Slattery","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bcp.2026.118298_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.821344","article-title":"JAK\/STAT signaling: molecular targets, therapeutic opportunities, and limitations of targeted inhibitions in solid malignancies","volume":"13","author":"Rah","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118298_b0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2026.118298_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.bcp.2026.118298_b0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12272-016-0795-8","article-title":"Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment","volume":"39","author":"Kim","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118298_b0120","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.2147\/JIR.S506964","article-title":"The dual roles of STAT3 in ferroptosis: mechanism, regulation and therapeutic potential","volume":"18","author":"Xie","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bcp.2026.118298_b0125","article-title":"High expression of CSF-1R predicts poor prognosis and CSF-1R(high) tumor-associated macrophages inhibit anti-tumor immunity in colon adenocarcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118298_b0130","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s00262-023-03496-2","article-title":"Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment","volume":"72","author":"Maldonado","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.bcp.2026.118298_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102381","article-title":"Insights into CSF-1R expression in the tumor microenvironment","volume":"12","author":"Tomassetti","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bcp.2026.118298_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010826","article-title":"Xing X: Disruption of GPSM1\/CSF1 signaling reprograms tumor-associated macrophages to overcome anti-PD-1 resistance in colorectal cancer","volume":"13","author":"Chen","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2026.118298_b0145","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","article-title":"Ferroptosis: a flexible constellation of related biochemical mechanisms","volume":"83","author":"Dixon","year":"2023","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bcp.2026.118298_b0150","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7150\/ijms.91446","article-title":"Construction and validation of novel ferroptosis-related risk score signature and prognostic prediction nomogram for patients with colorectal cancer","volume":"21","author":"Liu","year":"2024","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118298_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1530890","article-title":"Insights into CSF-1\/CSF-1R signaling: the role of macrophage in radiotherapy","volume":"16","author":"Shang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118298_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114884","article-title":"CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment","volume":"245","author":"Wen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118298_b0170","doi-asserted-by":"crossref","unstructured":"I.D.G.P. van, M. Matusiak, G.W. Charville, G, Spierenburg, S. Varma, D.R.C. Colburg, M.A.J. van de Sande, K. van Langevelde, D.G. Mohler, K.N. Ganjoo, et al: Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2022, 28(22):4934\u20134946.","DOI":"10.1158\/1078-0432.CCR-22-1898"},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12951-024-02584-4","article-title":"Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications","volume":"22","author":"Tong","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","article-title":"The JAK2\/STAT3\/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance","volume":"38","author":"Park","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43556-025-00322-2","article-title":"Microwave dynamic therapy induces ferroptosis in colorectal cancer by targeting PTK2B to regulate STAT3-mediated GPX4 expression","volume":"6","author":"Zhou","year":"2025","journal-title":"Molecular Biomedicine"},{"issue":"8","key":"10.1016\/j.bcp.2026.118298_b0195","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","article-title":"Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis","volume":"45","author":"Lai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0200","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178146","article-title":"Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages","volume":"10","author":"Sato","year":"2025","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.bcp.2026.118298_b0205","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1158\/1078-0432.CCR-16-3261","article-title":"First-in-human study of AMG 820, a monoclonal anti-colony-stimulating factor 1 receptor antibody, in patients with advanced solid tumors","volume":"23","author":"Papadopoulos","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","article-title":"JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases","volume":"25","author":"Dai","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bcp.2026.118298_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 Signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:26:59Z","timestamp":1791908819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"alternative-id":["S0006295226006374"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118298","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF1 inhibits ferroptosis in colorectal cancer cells by autocrine activation of the JAK\/STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118298"}}